AstraZeneca board approves delisting proposal

AstraZeneca board approves delisting proposal

Mumbai: AstraZeneca Pharma India Ltd said on Tuesday its board has approved a proposal to voluntarily delist the shares of the company from stock exchanges.

AstraZeneca Pharma AB, the parent company, holds 89.99% in AstraZeneca Pharma India.

Earlier in the day, shares of the company rose 20% to hit its daily upper trading limit after the company said it’s board will consider the delisitng proposal on Tuesday.

Close